Global Gestational Diabetes Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gestational Diabetes Treatment Market Size 2017-2028

2.1.2 Gestational Diabetes Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gestational Diabetes Treatment Segment by Type

2.2.1 Insulin

2.2.2 SGLT-2 Inhibitors

2.2.3 Alpha-glucosidase Inhibitors

2.2.4 Others

2.3 Gestational Diabetes Treatment Market Size by Type

2.3.1 Gestational Diabetes Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

2.4 Gestational Diabetes Treatment Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Gestational Diabetes Treatment Market Size by Application

2.5.1 Gestational Diabetes Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

3 Gestational Diabetes Treatment Market Size by Player

3.1 Gestational Diabetes Treatment Market Size Market Share by Players

3.1.1 Global Gestational Diabetes Treatment Revenue by Players (2020-2022)

3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Gestational Diabetes Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gestational Diabetes Treatment by Regions

4.1 Gestational Diabetes Treatment Market Size by Regions (2017-2022)

4.2 Americas Gestational Diabetes Treatment Market Size Growth (2017-2022)

4.3 APAC Gestational Diabetes Treatment Market Size Growth (2017-2022)

4.4 Europe Gestational Diabetes Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Gestational Diabetes Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gestational Diabetes Treatment Market Size by Country (2017-2022)

5.2 Americas Gestational Diabetes Treatment Market Size by Type (2017-2022)

5.3 Americas Gestational Diabetes Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gestational Diabetes Treatment Market Size by Region (2017-2022)

6.2 APAC Gestational Diabetes Treatment Market Size by Type (2017-2022)

6.3 APAC Gestational Diabetes Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gestational Diabetes Treatment by Country (2017-2022)

7.2 Europe Gestational Diabetes Treatment Market Size by Type (2017-2022)

7.3 Europe Gestational Diabetes Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gestational Diabetes Treatment by Region (2017-2022)

8.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gestational Diabetes Treatment Market Forecast

10.1 Global Gestational Diabetes Treatment Forecast by Regions (2023-2028)

10.1.1 Global Gestational Diabetes Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Gestational Diabetes Treatment Forecast

10.1.3 APAC Gestational Diabetes Treatment Forecast

10.1.4 Europe Gestational Diabetes Treatment Forecast

10.1.5 Middle East & Africa Gestational Diabetes Treatment Forecast

10.2 Americas Gestational Diabetes Treatment Forecast by Country (2023-2028)

10.2.1 United States Gestational Diabetes Treatment Market Forecast

10.2.2 Canada Gestational Diabetes Treatment Market Forecast

10.2.3 Mexico Gestational Diabetes Treatment Market Forecast

10.2.4 Brazil Gestational Diabetes Treatment Market Forecast

10.3 APAC Gestational Diabetes Treatment Forecast by Region (2023-2028)

10.3.1 China Gestational Diabetes Treatment Market Forecast

10.3.2 Japan Gestational Diabetes Treatment Market Forecast

10.3.3 Korea Gestational Diabetes Treatment Market Forecast

10.3.4 Southeast Asia Gestational Diabetes Treatment Market Forecast

10.3.5 India Gestational Diabetes Treatment Market Forecast

10.3.6 Australia Gestational Diabetes Treatment Market Forecast

10.4 Europe Gestational Diabetes Treatment Forecast by Country (2023-2028)

10.4.1 Germany Gestational Diabetes Treatment Market Forecast

10.4.2 France Gestational Diabetes Treatment Market Forecast

10.4.3 UK Gestational Diabetes Treatment Market Forecast

10.4.4 Italy Gestational Diabetes Treatment Market Forecast

10.4.5 Russia Gestational Diabetes Treatment Market Forecast

10.5 Middle East & Africa Gestational Diabetes Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Gestational Diabetes Treatment Market Forecast

10.5.2 South Africa Gestational Diabetes Treatment Market Forecast

10.5.3 Israel Gestational Diabetes Treatment Market Forecast

10.5.4 Turkey Gestational Diabetes Treatment Market Forecast

10.5.5 GCC Countries Gestational Diabetes Treatment Market Forecast

10.6 Global Gestational Diabetes Treatment Forecast by Type (2023-2028)

10.7 Global Gestational Diabetes Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Biocon Limited

11.1.1 Biocon Limited Company Information

11.1.2 Biocon Limited Gestational Diabetes Treatment Product Offered

11.1.3 Biocon Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Biocon Limited Main Business Overview

11.1.5 Biocon Limited Latest Developments

11.2 Eli Lilly

11.2.1 Eli Lilly Company Information

11.2.2 Eli Lilly Gestational Diabetes Treatment Product Offered

11.2.3 Eli Lilly Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Eli Lilly Main Business Overview

11.2.5 Eli Lilly Latest Developments

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Information

11.3.2 Novo Nordisk Gestational Diabetes Treatment Product Offered

11.3.3 Novo Nordisk Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novo Nordisk Main Business Overview

11.3.5 Novo Nordisk Latest Developments

11.4 Boehringer Ingelheim GmbH

11.4.1 Boehringer Ingelheim GmbH Company Information

11.4.2 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered

11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Boehringer Ingelheim GmbH Main Business Overview

11.4.5 Boehringer Ingelheim GmbH Latest Developments

11.5 Sanofi S.A.

11.5.1 Sanofi S.A. Company Information

11.5.2 Sanofi S.A. Gestational Diabetes Treatment Product Offered

11.5.3 Sanofi S.A. Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Sanofi S.A. Main Business Overview

11.5.5 Sanofi S.A. Latest Developments

11.6 Sun Pharmaceutical Industries Limited

11.6.1 Sun Pharmaceutical Industries Limited Company Information

11.6.2 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered

11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Sun Pharmaceutical Industries Limited Main Business Overview

11.6.5 Sun Pharmaceutical Industries Limited Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Gestational Diabetes Treatment Product Offered

11.7.3 Merck Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Novartis

11.8.1 Novartis Company Information

11.8.2 Novartis Gestational Diabetes Treatment Product Offered

11.8.3 Novartis Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Novartis Main Business Overview

11.8.5 Novartis Latest Developments

11.9 Adocia

11.9.1 Adocia Company Information

11.9.2 Adocia Gestational Diabetes Treatment Product Offered

11.9.3 Adocia Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Adocia Main Business Overview

11.9.5 Adocia Latest Developments

11.10 Peptron

11.10.1 Peptron Company Information

11.10.2 Peptron Gestational Diabetes Treatment Product Offered

11.10.3 Peptron Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Peptron Main Business Overview

11.10.5 Peptron Latest Developments

11.11 AstraZeneca plc

11.11.1 AstraZeneca plc Company Information

11.11.2 AstraZeneca plc Gestational Diabetes Treatment Product Offered

11.11.3 AstraZeneca plc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 AstraZeneca plc Main Business Overview

11.11.5 AstraZeneca plc Latest Developments

11.12 Pfizer, Inc

11.12.1 Pfizer, Inc Company Information

11.12.2 Pfizer, Inc Gestational Diabetes Treatment Product Offered

11.12.3 Pfizer, Inc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Pfizer, Inc Main Business Overview

11.12.5 Pfizer, Inc Latest Developments

11.13 Takeda Pharmaceutical Company Ltd

11.13.1 Takeda Pharmaceutical Company Ltd Company Information

11.13.2 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered

11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Takeda Pharmaceutical Company Ltd Main Business Overview

11.13.5 Takeda Pharmaceutical Company Ltd Latest Developments

11.14 Abbott

11.14.1 Abbott Company Information

11.14.2 Abbott Gestational Diabetes Treatment Product Offered

11.14.3 Abbott Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Abbott Main Business Overview

11.14.5 Abbott Latest Developments

11.15 Antares Pharma

11.15.1 Antares Pharma Company Information

11.15.2 Antares Pharma Gestational Diabetes Treatment Product Offered

11.15.3 Antares Pharma Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Antares Pharma Main Business Overview

11.15.5 Antares Pharma Latest Developments

11.16 INJEX Pharma AG

11.16.1 INJEX Pharma AG Company Information

11.16.2 INJEX Pharma AG Gestational Diabetes Treatment Product Offered

11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 INJEX Pharma AG Main Business Overview

11.16.5 INJEX Pharma AG Latest Developments

11.17 Daiichi Sankyo

11.17.1 Daiichi Sankyo Company Information

11.17.2 Daiichi Sankyo Gestational Diabetes Treatment Product Offered

11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Daiichi Sankyo Main Business Overview

11.17.5 Daiichi Sankyo Latest Developments

12 Research Findings and Conclusion

Table 1. Gestational Diabetes Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Insulin

Table 3. Major Players of SGLT-2 Inhibitors

Table 4. Major Players of Alpha-glucosidase Inhibitors

Table 5. Major Players of Others

Table 6. Gestational Diabetes Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Gestational Diabetes Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

Table 9. Gestational Diabetes Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Gestational Diabetes Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

Table 12. Global Gestational Diabetes Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Gestational Diabetes Treatment Revenue Market Share by Player (2020-2022)

Table 14. Gestational Diabetes Treatment Key Players Head office and Products Offered

Table 15. Gestational Diabetes Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Gestational Diabetes Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2017-2022)

Table 20. Americas Gestational Diabetes Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Gestational Diabetes Treatment Market Size Market Share by Country (2017-2022)

Table 22. Americas Gestational Diabetes Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

Table 24. Americas Gestational Diabetes Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

Table 26. APAC Gestational Diabetes Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Gestational Diabetes Treatment Market Size Market Share by Region (2017-2022)

Table 28. APAC Gestational Diabetes Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

Table 30. APAC Gestational Diabetes Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

Table 32. Europe Gestational Diabetes Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Gestational Diabetes Treatment Market Size Market Share by Country (2017-2022)

Table 34. Europe Gestational Diabetes Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

Table 36. Europe Gestational Diabetes Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Gestational Diabetes Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Gestational Diabetes Treatment

Table 45. Key Market Challenges & Risks of Gestational Diabetes Treatment

Table 46. Key Industry Trends of Gestational Diabetes Treatment

Table 47. Global Gestational Diabetes Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Gestational Diabetes Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Gestational Diabetes Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 53. Biocon Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 54. Biocon Limited Gestational Diabetes Treatment Product Offered

Table 55. Biocon Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Biocon Limited Main Business

Table 57. Biocon Limited Latest Developments

Table 58. Eli Lilly Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 59. Eli Lilly Gestational Diabetes Treatment Product Offered

Table 60. Eli Lilly Main Business

Table 61. Eli Lilly Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Eli Lilly Latest Developments

Table 63. Novo Nordisk Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 64. Novo Nordisk Gestational Diabetes Treatment Product Offered

Table 65. Novo Nordisk Main Business

Table 66. Novo Nordisk Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Novo Nordisk Latest Developments

Table 68. Boehringer Ingelheim GmbH Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 69. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered

Table 70. Boehringer Ingelheim GmbH Main Business

Table 71. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Boehringer Ingelheim GmbH Latest Developments

Table 73. Sanofi S.A. Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 74. Sanofi S.A. Gestational Diabetes Treatment Product Offered

Table 75. Sanofi S.A. Main Business

Table 76. Sanofi S.A. Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Sanofi S.A. Latest Developments

Table 78. Sun Pharmaceutical Industries Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 79. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered

Table 80. Sun Pharmaceutical Industries Limited Main Business

Table 81. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Sun Pharmaceutical Industries Limited Latest Developments

Table 83. Merck Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 84. Merck Gestational Diabetes Treatment Product Offered

Table 85. Merck Main Business

Table 86. Merck Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Merck Latest Developments

Table 88. Novartis Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 89. Novartis Gestational Diabetes Treatment Product Offered

Table 90. Novartis Main Business

Table 91. Novartis Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Novartis Latest Developments

Table 93. Adocia Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 94. Adocia Gestational Diabetes Treatment Product Offered

Table 95. Adocia Main Business

Table 96. Adocia Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Adocia Latest Developments

Table 98. Peptron Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 99. Peptron Gestational Diabetes Treatment Product Offered

Table 100. Peptron Main Business

Table 101. Peptron Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Peptron Latest Developments

Table 103. AstraZeneca plc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 104. AstraZeneca plc Gestational Diabetes Treatment Product Offered

Table 105. AstraZeneca plc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. AstraZeneca plc Main Business

Table 107. AstraZeneca plc Latest Developments

Table 108. Pfizer, Inc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 109. Pfizer, Inc Gestational Diabetes Treatment Product Offered

Table 110. Pfizer, Inc Main Business

Table 111. Pfizer, Inc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Pfizer, Inc Latest Developments

Table 113. Takeda Pharmaceutical Company Ltd Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 114. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered

Table 115. Takeda Pharmaceutical Company Ltd Main Business

Table 116. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Takeda Pharmaceutical Company Ltd Latest Developments

Table 118. Abbott Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 119. Abbott Gestational Diabetes Treatment Product Offered

Table 120. Abbott Main Business

Table 121. Abbott Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Abbott Latest Developments

Table 123. Antares Pharma Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 124. Antares Pharma Gestational Diabetes Treatment Product Offered

Table 125. Antares Pharma Main Business

Table 126. Antares Pharma Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Antares Pharma Latest Developments

Table 128. INJEX Pharma AG Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 129. INJEX Pharma AG Gestational Diabetes Treatment Product Offered

Table 130. INJEX Pharma AG Main Business

Table 131. INJEX Pharma AG Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. INJEX Pharma AG Latest Developments

Table 133. Daiichi Sankyo Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors

Table 134. Daiichi Sankyo Gestational Diabetes Treatment Product Offered

Table 135. Daiichi Sankyo Main Business

Table 136. Daiichi Sankyo Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Daiichi Sankyo Latest Developments

List of Figures

Figure 1. Gestational Diabetes Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gestational Diabetes Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gestational Diabetes Treatment Market Size Market Share by Type in 2021

Figure 7. Gestational Diabetes Treatment in Hospital Pharmacies

Figure 8. Global Gestational Diabetes Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Gestational Diabetes Treatment in Retail Pharmacies

Figure 10. Global Gestational Diabetes Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Gestational Diabetes Treatment in Online Pharmacies

Figure 12. Global Gestational Diabetes Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Gestational Diabetes Treatment Market Size Market Share by Application in 2021

Figure 14. Global Gestational Diabetes Treatment Revenue Market Share by Player in 2021

Figure 15. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Gestational Diabetes Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Gestational Diabetes Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Gestational Diabetes Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Gestational Diabetes Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Gestational Diabetes Treatment Value Market Share by Country in 2021

Figure 21. Americas Gestational Diabetes Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Gestational Diabetes Treatment Market Size Market Share by Application in 2021

Figure 23. United States Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Gestational Diabetes Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Gestational Diabetes Treatment Market Size Market Share by Application in 2021

Figure 29. China Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Gestational Diabetes Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Gestational Diabetes Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Gestational Diabetes Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Gestational Diabetes Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Gestational Diabetes Treatment Market Size 2023-2028 ($ Millions)